Association between Serum Uric Acid Levels and Sleep Variables: Results from the National Health and Nutrition Survey 2005–2008 by Wiener, R Constance
Faculty Scholarship
2012
Association between Serum Uric Acid Levels and
Sleep Variables: Results from the National Health
and Nutrition Survey 2005–2008
R Constance Wiener
West Virginia University, rwiener2@hsc.wvu.edu
Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications
Part of the Public Health Commons
This Article is brought to you for free and open access by The Research Repository @ WVU. It has been accepted for inclusion in Faculty Scholarship
by an authorized administrator of The Research Repository @ WVU. For more information, please contact ian.harmon@mail.wvu.edu.
Digital Commons Citation
Wiener, R Constance, "Association between Serum Uric Acid Levels and Sleep Variables: Results from the National Health and
Nutrition Survey 2005–2008" (2012). Faculty Scholarship. 910.
https://researchrepository.wvu.edu/faculty_publications/910
Hindawi Publishing Corporation
International Journal of Inflammation
Volume 2012, Article ID 363054, 8 pages
doi:10.1155/2012/363054
Research Article
Association between SerumUric Acid Levels and Sleep Variables:
Results from the National Health and Nutrition Survey 2005–2008
R. ConstanceWiener1, 2 and Anoop Shankar2
1 Department of Dental Practice and Rural Health, Health Sciences North, West Virginia University, P.O. Box 9448,
Morgantown, WV 26506, USA
2 Department of Epidemiology, School of Public Health, Health Sciences North, West Virginia University, P.O. Box 9190,
Morgantown, WV 26506, USA
Correspondence should be addressed to Anoop Shankar, ashankar@hsc.wvu.edu
Received 23 February 2012; Revised 16 July 2012; Accepted 16 July 2012
Academic Editor: Juan Carlos Kaski
Copyright © 2012 R. C. Wiener and A. Shankar. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Sleep disordered breathing as well as high serum uric acid levels are independent risk factors for cardiovascular disease. However,
studies evaluating the relationship between sleep-disordered breathing and hyperuricemia are limited.We examined the 2005–2008
National Health and Nutrition Examination survey’s sleep variables and high serum uric acid among 6491 participants aged ≥ 20
years. The sleep variables included sleep duration, snoring, snorting, and daytime sleepiness. The main outcome was high serum
uric acid level, defined as levels of serum uric acid > 6.8mg/dL in males and > 6.0mg/dL in females. We found that snoring more
than 5 nights per week, daytime sleepiness, and an additive composite score of sleep variables were associated with high serum uric
acid in the age- , sex-adjusted model and in a multivariable model adjusting for demographic and lifestyle/behavioral risk factors.
The association was attenuated with the addition of variables related to clinical outcomes such as depression, diabetes, hyper-
tension, and high-cholesterol levels. Our results indicate a positive relationship between sleep variables, including the presence of
snoring, snorting, and daytime sleepiness, and high serum uric acid levels.
1. Introduction
Sleep-disordered breathing (SDB) is a spectrum of disrup-
tive breathing patterns in sleep in which the upper airway is
partially or completely obstructed resulting in airflow symp-
toms which may vary from mild to severe airflow changes,
oxygen desaturation, and arousals [1, 2], or there may be
central involvement (central sleep apnea) in which there is
a lack or loss of the drive to breathe during sleep. Central
sleep apnea occurs as a result of high altitude-induced
periodic breathing, idiopathic CSA, narcotic-induced central
apnea, obesity hypoventilation syndrome, and Cheyne-
Stokes breathing [3]. SDB has been associated with hyperten-
sion, cardiovascular disease, and increased risk of fatal and
nonfatal cardiovascular events [4–7].
Higher levels of serum uric acid have been shown
to be associated with increased risk of hypertension, [8–
14] prehypertension, [15] peripheral arterial disease, [16]
diabetes mellitus [17], and cardiovascular disease through
inflammatory pathways [4–7]. Animal studies have suggested
that SDB is related to elevations in uric acid levels [1, 18].
The hypothesized mechanism is that during hypoxia, there
is increased adenosine triphosphate degradation and the
release of purine intermediates (adenosine, inosine, hypo-
xanthine, and xanthine) as well as the purine catabolic end
product, and uric acid. [1, 18]. However, the association bet-
ween SDB and high uric acid levels in humans is not clear.
While some studies [18–21] have reported an association
between SDB markers and high serum uric acid levels, others
have not [22, 23]. Also, most of the previous studies had
small sample sizes and did not examine the association by
gender and race/ethnicity. In this context, we examined the
association between sleep duration, snoring, snorting, and
daytime sleepiness and high serum uric acid in a large,
nationally representative sample of US adults, examining
the confounding by age, gender, race/ethnicity, education,
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smoking status, alcohol intake, physical activity, body mass
index, depression, diabetes, and total cholesterol. In this
hypothesis generating study, our research hypothesis was that
high levels of serum uric acid would be associated with the
sleep variables of sleep duration, snoring, snorting, daytime
sleepiness, and an additive summary score of the variables.
2. Methods
Data from the National Health and Nutrition Examination
Survey (NHANES) 2005-2006 and 2007-08 were used in
this study. The study design and study methodology of the
NHANES are available in details elsewhere [24, 25]. In brief,
the national survey is charged to monitor the health and
dietary status of children and adults in the United States.
The survey design utilizes stratified probability samples in
multiple stages to develop an accurate representation of
the noninstitutionalized civilian population [24]. NHANES
oversamples non-Hispanic blacks andMexican Americans to
provide an adequate sample size to analyze the data based
upon race/ethnicity. The methods employed in the survey
included clinical, physical, and laboratory examinations as
well as interviews. A sampling algorithm was used, taking
into account counties, blocks, households, and individuals
within a household [24].
Of the 20497 participants in NHANES 2005-2006 and
2007-2008, there were 10914 who were age 20 years or older.
We excluded participants who were pregnant (n = 393), had
prevalent cardiovascular disease (n = 1275), had missing
sleep variables (n = 1375), or had missing uric acid vari-
ables or other missing variables for our multivariable logistic
regression models (n = 1380). Uric acid data in the labo-
ratory portion of the NHANES survey was provided by indi-
viduals aged 12 years or older. The final analysis consisted
of 6491 participants for whom complete multivariable infor-
mation was available.
2.1. Outcome of Interest: High Serum Uric Acid. High serum
uric acid was defined as serum levels of uric acid > 6.8mg/dL
in males based upon clinical usefulness, and previous
research [26–28], as defining hyperuricemia is based on the
concentration equal or are above the limit of urate solubility
[28]. Likewise, high uric acid was defined as >6.0mg/dL for
females based upon previous research and clinical usefulness
[29]. The laboratory collection procedure is available in the
NHANES Laboratory Procedures Manual [24, 25].
2.2. Assessment of Exposure: Sleep Variables. Sleep variables
were self-reported by the participants. The NHANES inter-
view questions which regarded sleep behavior were “How
much sleep do you usually get at night and on weekdays or
workdays?”; “In the past 12 months, how often did you snore
while you were sleeping?”; “In the past 12 months, how
often did you snort, gasp, or stop breathing while you were
asleep?”; “In the past month, how often did you feel exces-
sively or overly sleepy during the day?” From the four sleep
questions, we derived four sleep variables identified as sleep
duration; snoring; snorting; daytime sleepiness. The 5 cat-
egories for sleep duration consisted of less than or equal
to 5 hours of sleep, 6 hours of sleep, 7 hours of sleep, 8
hours of sleep, and greater than or equal to 9 hours of
sleep. Our snorting, and snoring variables were categorized
from the participants’ responses of “never or rare” to the
corresponding 0–2 times/week descriptor, “occasional” to 3-
4 times/week, and “frequent” to 5 or more times/week. Our
daytime sleepiness variable combined participants’ responses
of “never or rare,” “sometimes,” and “often” into the 0–15
times/month combination of those responses and “almost
always,” using the 16 or more times/month descriptor.
An ad hoc additive composite score of the sleep variables
was designed to study the simultaneous additive effect of
the multiple sleep variables and was based upon previous
research [30–32]. To create the additive composite score, we
dichotomized the four sleep variables, based upon clinical
significance, and then we combined them. Sleep duration
was dichotomized into a category of 5 hours of sleep or
less and a category of greater than 5 hours of sleep. Snoring
was dichotomized into snoring 3-4 nights or more per week
and snoring less than 3-4 nights per week. Snorting was
dichotomized into snorting 3-4 nights or more per week
and snorting less than 3-4 nights per week. The daytime
sleepiness variable was created as a dichotomized variable
with 16 times or more per month as the cut-point. Each
positive category was assigned a score of 1. The individual
scores were accumulated into the additive composite score of
sleep variables, which therefore had a range of values from
0 to 4. The additive composite score 0, represented that no
sleep variables were present; whereas a score of 4 indicated
the presence of all 4 variables.
2.3. Assessment of Covariates. The covariates used from the
NHANES survey were age, sex, race/ethnicity, education,
smoking, alcohol intake, physical activity, body mass index,
hypertension, depression, diabetes, and cholesterol. Self-
report was the basis for age, sex, race/ethnicity, education,
smoking, alcohol intake, depression, and diabetes. The ques-
tions posed for alcohol use asked the amount of alcohol
intake in grams/day. Current alcohol use was defined as 1
or more alcoholic drinks in the previous year. The educa-
tional level was categorized as less than high school gradu-
ation, high school graduation, and more than high school
graduation. Smoking status was defined as never use (less
than 100/lifetime), current use (a history of 100 or more
cigarettes and continued use), and former use (a history of
100 or more cigarettes and no longer smoking). Moderate
physical activity was defined as activities which increased
the heart and breathing rate such as walking briskly, cycling,
swimming, or playing golf for at least 10 minutes per week.
Depression was self-identified as feeling down, depressed, or
hopeless more than half of the days or nearly every day within
the previous two weeks.
Physical and laboratory evaluations were conducted by
the medical examination center (MEC). Body mass index
(BMI) was derived as weight in kilograms divided by height
in meters-squared. A mercury sphygmomanometer was used
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0 1 2 ≥3
Number at risk 2595 2591 1041 264
Women (%) 59.3 46.6 39.2 39.5 <0.0001
Age (years) 43.4± 0.5 45.9± 0.6 46.0± 0.5 43.6± 0.9 <0.0001
Race/Ethnicity (%)
Non-Hispanic whites 74.2 72.0 71.8 65.8 0.0476
Non-Hispanic blacks 8.8 9.9 12.3 16.5 <0.0001
Mexican Americans 7.6 8.9 7.2 4.6 0.2126
Others 9.4 9.3 8.8 13.1 0.6188
Education categories (%)
Below high school 15.3 17.1 19.3 22.8 0.0003
High school 21.3 25.8 27.8 32.9 <0.0001
Above high school 63.4 57.1 52.9 44.3 <0.0001
Smoking (%)
Never smoker 58.6 50.9 45.4 38.0 <0.0001
Former smoker 23.4 23.2 25.2 23.6 0.5163
Current smoker 17.9 25.9 29.3 38.5 <0.0001
Alcohol intake, current drinker (%) 74.4 75.3 74.8 62.2 0.0597
Moderate physical activity (%) 58.8 51.9 46.0 44.0 <0.0001
Body mass index (%)
Normal weight 45.4 27.3 18.4 17.8 <0.0001
Overweight 33.1 36.0 32.5 26.8 0.4777
Obese 21.5 36.7 49.1 55.4 <0.0001
Depression (%) 3.6 4.1 9.9 13.4 <0.0001
Diabetes (%) 5.9 10.0 12.9 15.6 <0.0001
Total cholesterol (mg/dL) 197.9± 0.9 201.3± 1.0 202.5± 1.7 203.3± 3.5 0.0125
Uric acid (mg/dL) 5.2± 0.04 5.5± 0.03 5.7± 0.1 6.0± 0.1 <0.0001
∗
Data presented are weighted row percentages or mean values ± standard error (SE).
to take 3 blood pressure measurements and the mean systolic
and diastolic were recorded. High blood pressure was defined
as a blood pressure with a mean systolic of 140mmHg or
above, or a mean diastolic blood pressure of 9mmHg or
above, or a positive response to the use of blood pressure
reducing medications.
Total serum cholesterol levels were determined enzymat-
ically using the Roche Hitachi 717 in 2005, Roche Hitachi
717 and 912 in 2006, and the Roche Modular P chemistry
analyzer in 2007-2008. The details of blood collection,
processing, and analysis are available in the Laboratory Pro-
cedures Manuals [24, 25].
2.4. Statistical Analysis. Descriptive characteristics of the
study participants by high serum uric acid (serum levels of
uric acid > 6.8mg/dL in males and > 6.0mg/dL in females)
were determined utilizing the chi-square test or analysis of
variance, as needed. The association of the sleep variables
(sleep duration, snoring, snorting, daytime sleepiness, and
the adhoc additive composite score of sleep variables and
serum uric acid were evaluated with three logistic regression
models. We completed (1) an age-(years), gender-(male,
female) adjusted logistic regression model; (2) a multivari-
able model 1 in which we adjusted for age (years), gender
(male, female), race/ethnicity (non-Hispanic whites, non-
Hispanic blacks, Mexican Americans, and others), edu-
cation (below high school, high school, and above high
school), smoking (never smoker, former smoker, and current
smoker), alcohol intake (absent, present), moderate physical
activity (absent, present) and body mass index (obese,
nonobese) and (3) a multivariable model 2 in which we also
included hypertension (absent, present), depression (absent,
present), diabetes (absent, present), and total cholesterol
(mg/dL). In these analyses, we used logistic regression
models with the categorical high serum uric acid (level >
6.8mg/dL in males, and > 6.0mg/dL in females) as the out-
come variable. Trend tests were performed with the sleep
variables and the summary score as an ordinal variable in the
corresponding multivariable models. Subgroup analysis by
gender, and race/ethnicity were also conducted. To examine
potential collinearity, regression diagnostics for collinearity
were performed; there were no significant collinearity of
variables included in the multivariable model. The analyses
were weighted to adjust for unequal probabilities of selection,
oversampling, and nonresponse by using SUDAAN (version
4 International Journal of Inflammation







1∗ OR (95% CI)
Multivariable-model
2† OR (95% CI)
Sleep duration (hours)
≤5 hrs 997 (23.6) 1.15 (0.96–1.38) 1.16 (0.96–1.40) 1.01 (0.82–1.26)
6 hrs 1505 (20.8) 0.96 (0.82–1.13) 0.96 (0.82–1.14) 0.95 (0.81–1.13)
7 hrs 1871 (21.4) 1 (referent) 1 (referent) 1 (referent)
8 hrs 1710 (17.8) 0.81 (0.69–0.96) 0.82 (0.69–0.96) 0.83 (0.70–0.99)
≥9 hrs 408 (20.7) 1.05 (0.81–1.37) 1.07 (0.82–1.40) 1.15 (0.86–1.53)
P-trend 0.0191 0.0304 0.4799
Snoring (nights/week)
0–2 3140 (16.2) 1 (referent) 1 (referent) 1 (referent)
3-4 1251 (20.8) 1.25 (0.98–1.58) 1.25 (0.98–1.59) 1.06 (0.83–1.35)
≥5 2100 (27.2) 1.64 (1.41–1.90) 1.69 (1.46–1.96) 1.21 (1.02–1.43)
P-trend <0.0001 <0.0001 0.0278
Snorting (nights/week)
0–2 5693 (19.8) 1 (referent) 1 (referent) 1 (referent)
3-4 417 (25.9) 1.19 (0.95–1.50) 1.20 (0.95–1.51) 1.02 (0.81–1.30)
≥5 381 (26.3) 1.26 (0.93–1.71) 1.29 (0.94–1.75) 0.89 (0.62–1.28)
P-trend 0.0602 0.0467 0.5622
Daytime sleepiness (times/month)
0–15 6142 (20.4) 1 (referent) 1 (referent) 1 (referent)
≥16 349 (24.4) 1.38 (1.06–1.81) 1.42 (1.08–1.88) 1.28 (0.96–1.71)
P-trend 0.0167 0.0126 0.0968
Additive composite score
0 2595 (16.4) 1 (referent) 1 (referent) 1 (referent)
1 2591 (21.8) 1.27 (1.08–1.50) 1.30 (1.11–1.54) 1.06 (0.90–1.26)
2 1041 (26.7) 1.59 (1.29–1.95) 1.63 (1.32–2.01) 1.13 (0.91–1.41)
≥3 264 (29.3) 1.88 (1.43–2.47) 1.96 (1.48–2.59) 1.27 (0.94–1.71)
P-trend <0.0001 <0.0001 0.1231
∗
Model 1: Adjusted for age (years), gender (male, female), race/ethnicity (non-Hispanic whites, non-Hispanic blacks, Mexican Americans, and others),
education (below high school, high school, and above high school), smoking (never smoker, former smoker, and current smoker), and alcohol intake (absent,
present) in a multivariable logistic regression model.
†Model 2: Additional adjusted for physical activity (moderate physical activity), body mass index (obese, nonobese), depression (absent, present), diabetes
(absent, present), and total cholesterol (mg/dL) in a multivariable logistic regression model.
Abbreviations: CI: confidence interval; OR: odds ratio.
8.0; Research Triangle Institute, Research Triangle Park, NC)
and SAS (version 9.1.; SAS Institute, Cary, NC) software.
3. Results
A tabular description of the study population based upon
the additive composite score of sleep variables is presented in
Table 1. There were more participants who had a composite
score of sleep variables of zero who were educated above high
school, who exercisedmoderately, who had lower cholesterol,
who were normal weight, not depressed, and who did not
have diabetes.
Overall, the study sample population was a middle-
aged (mean age 44.8 years) multiethnic sample consisting of
non-Hispanic whites (72.6%), non-Hispanic blacks (10.0%),
and Mexican Americans and other race/ethnicities (17.4%).
The majority (58.4%) of this sample was educated above
the high school level, and consisted of current drinkers
(74.3%). There was an equal distribution of normal weight,
overweight, and obese BMI groups. Never smokers and
former smokers comprised 76.4% of the sample, (52.8% and
23.6%, resp.), and current smokers comprised 23.6%. Also,
depression was reported by 5.1% and diabetes mellitus was
present in 8.9% of the subjects. The mean total cholesterol
was 200.1mg/dL.
Table 2 presents the associations between various sleep
variables, including sleep duration, snoring, snorting, day-
time sleepiness, and the additive composite score of sleep
variables and their association with high serum uric acid,
defined as serum levels > 6.8mg/dL in males and 6.0mg/dL
in females. We found that sleep duration was significantly
associated with high serum uric acid for the sleep duration
of 8 hours, which was protective in each of the models.
The adjusted odds ratios for daytime sleepiness, and the
additive composite score were associated with high serum
International Journal of Inflammation 5







1∗ OR (95% CI)
Multivariable-model
2† OR (95% CI)
Men
0 1152 (23.9) 1 (referent) 1 (referent) 1 (referent)
1 1387 (26.8) 1.16 (0.95–1.41) 1.19 (0.98–1.45) 1.05 (0.88–1.26)
2 632 (29.8) 1.34 (1.01–1.77) 1.40 (1.05–1.87) 1.08 (0.81–1.44)
≥3 160 (33.0) 1.56 (1.10–2.23) 1.70 (1.18–2.45) 1.26 (0.86–1.84)
P-trend 0.0117 0.0039 0.3517
Women
0 1443 (11.2) 1 (referent) 1 (referent) 1 (referent)
1 1204 (16.0) 1.41 (1.01–1.97) 1.41 (1.00–1.97) 0.99 (0.68–1.45)
2 409 (22.1) 2.12 (1.55–2.88) 2.06 (1.50–2.84) 1.21 (0.87–1.70)
≥3 104 (23.8) 2.48 (1.39–4.43) 2.31 (1.25–4.28) 1.12 (0.56–2.23)
P-trend <0.0001 <0.0001 0.3906
∗
Model 1: Adjusted for age (years), race/ethnicity (non-Hispanic whites, non-Hispanic blacks, Mexican Americans, and others), education (below high school,
high school, and above high school), smoking (never smoker, former smoker, and current smoker), and alcohol intake (absent, present) in a multivariable
logistic regression model.
†Model 2: Additional adjusted for physical activity (moderate physical activity), body mass index (obese, nonobese), depression (absent, present), diabetes
(absent, present), and total cholesterol (mg/dL) in a multivariable logistic regression model.
Abbreviations: CI, confidence interval; OR, odds ratio.
uric acid in the age-, gender-adjusted model. The associa-
tions were maintained and had increased in multivariable
model 1. The associations were attenuated for multivariable
model 2. The adjusted odds ratios’ confidence intervals for
multivariable model 2 included the value of 1, indicating that
the associations for multivariable model 2 may be due to
chance. Similarly, the adjusted odds ratios for snorting had
confidence intervals which included the value of 1, indicating
that the associations of uric acid and snorting may be due to
chance.
The adjusted odds ratios for snoring 5 hours or more
were significant across all models.
In terms of trend, there was a significant P-trend for sleep
duration, snoring, daytime sleepiness, and with the additive
composite score of sleep variables across the age-, sex-
adjusted and multivariable 1 logistic regression models. The
trend continued with significance for snoring in the multi-
variable model 2.
Table 3 presents the association between the additive
composite score and high serum uric acid by gender. Con-
sistent with findings in the whole sample, we found that
a higher additive composite score was associated with high
serum uric acid in the age-adjusted logistic regression model
and the multivariable model 1 in both men as well as women
(although the confidence interval for an additive composite
score of 1 for men could be due to chance due to the 95%
confidence interval including the value of 1). With addi-
tional adjustment for clinical variables, the association was
attenuated. A significant P-trend existed in the age and mul-
tivariable model 1 for both genders.
Similarly, Table 4 presents the association between the
additive composite score of sleep variables and high serum
uric acid by race/ethnicity. Here also, we found that higher
additive composite score of sleep variables as well as the
























Additive compositive score (number of sleep variables)
P < 0.0001
Figure 1: Multivariable-adjustedmean uric acid levels in relation to
increasing additive composite score of sleep variables. Multivariable
model adjusted for age (years), gender (male, female), education
(below high school, high school, and above high school), smoking
(never smoker, former smoker, and current smoker), and alcohol
intake (absent, present).
age-, sex-adjusted and the multivariable model 1 in all major
racial/ethnic groups studied, but was no longer associated
with additional adjustments in the multivariable model 2.
The confidence intervals included the value of 1, indicating
the results may be due to chance for non-Hispanic whites,
and Mexican Americans with additive composite scores of
1 in the age-, sex-adjusted model. Also, for Mexican Ame-
ricans, the confidence interval included the value of 1 in
the additive composite score of 1 category in multivariable
model 1.
Figure 1 displays the mean uric acid levels in relation to
the additive composite scores of the sleep variables with the
95% confidence levels in age-, sex-adjusted model. The uric
acid levels increased from amean of 5.33mg/dLwith no sleep
6 International Journal of Inflammation







1† OR (95% CI)
Multivariable-model
2‡ OR (95% CI)
Non-Hispanic whites
0 1366 (17.4) 1 (referent) 1 (referent) 1 (referent)
1 1238 (22.2) 1.21 (0.99–1.47) 1.25 (1.02–1.53) 1.02 (0.83–1.26)
2 486 (26.1) 1.43 (1.12–1.83) 1.50 (1.16–1.95) 1.04 (0.80–1.35)
≥3 122 (30.3) 1.86 (1.30–2.65) 2.05 (1.38–3.03) 1.35 (0.87–2.11)
P-trend <0.0001 <0.0001 0.3788
Non-Hispanic blacks
0 484 (16.1) 1 (referent) 1 (referent) 1 (referent)
1 498 (26.0) 1.75 (1.35–2.26) 1.72 (1.32–2.24) 1.45 (1.05–1.98)
2 253 (30.9) 2.14 (1.43–3.21) 2.12 (1.42–3.17) 1.46 (0.95–2.24)
≥3 74 (30.9) 2.18 (1.23–3.88) 2.15 (1.20–3.86) 1.51 (0.79–2.91)
P-trend 0.0003 0.0004 0.0957
Mexican Americans
0 459 (12.0) 1 (referent) 1 (referent) 1 (referent)
1 541 (15.4) 1.28 (0.89–1.83) 1.29 (0.89–1.88) 1.00 (0.67–1.50)
2 174 (20.5) 1.78 (1.10–2.90) 1.82 (1.10–3.02) 1.28 (0.76–2.17)
≥3 28 (26.9) 2.64 (1.01–6.88) 2.92 (1.09–7.83) 2.10 (0.68–6.54)
P-trend 0.0043 0.0050 0.2120
∗
No separate analysis by other race/ethnicities due to small sample size.
†Model 1: Adjusted for age (years), gender (male, female), education (below high school, high school, and above high school), smoking (never smoker, former
smoker, and current smoker), and alcohol intake (absent, present) in a multivariable logistic regression model.
‡Model 2: Additional adjusted for physical activity (moderate physical activity), body mass index (obese, nonobese), depression (absent, present), diabetes
(absent, present), and total cholesterol (mg/dL) in a multivariable logistic regression model.
Abbreviations: CI: confidence interval; OR: odds ratio.
variables to 5.87mg/dL with 3 or more sleep variables (P <
0.0001).
4. Discussion
In a large, national, multiethnic, cross-sectional sample of
US adults, we found a significant initial association between
symptoms of daytime sleepiness, snoring more than 5
nights per week and the additive composite score with high
serum uric acid in an age-, gender-adjusted model, and a
multivariable model adjusting for age, gender, race/ethnicity,
education, smoking, alcohol intake, physical activity, and
body mass index. However, the association was attenuated
and not significant with the addition of clinical factors such
as hypertension, depression, diabetes, and total cholesterol.
Our initial finding of an association is significant because
it has been shown that even mild hyperuricemia is associated
with hypertension, diabetes, peripheral artery disease, and
cardiovascular disease [8–17]. It is possible that hyperurice-
mia associated with the sleep variables may therefore explain
part of the increased-cardiovascular disease risk seen in SDB.
The exact biological mechanism underlying an association
between the sleep variables and high serum uric acid is not
clear. However, previous animal studies have shown that
intermittent hypoxia and resultant oxygen desaturation in
SDBmay be associated with subsequent activation of inflam-
matory pathways and that serum uric acid levels are also
elevated in the process [19]. In a cross-over study of 10 men
exposed to 6 hours of intermittent hypoxia for 4 days, the
researchers showed an increase in uric acid production dur-
ing the 4 days of intermittent hypoxia and suggested that
this elevation in uric acid reflects the production of reactive
oxygen species through the xanthine oxidase pathway [33].
In the current study, positive associations between day-
time sleepiness, snoring more than 5 nights per week, and
the additive composite score with high serum uric acid were
found to be initially present in the multivariable model 1,
where we adjusted for lifestyle risk factors, but were found
to be attenuated and no longer present in the multivariable
model 2, where we additionally controlled for clinical factors
such as hypertension, depression, diabetes, and total choles-
terol. A similar pattern of association emerged when we per-
formed a subgroup analysis by gender. This indicates that
part of the initially observed association of the sleep variables
and high serum uric acid may be mediated by the clinical
factors such as hypertension, depression, diabetes, and total
cholesterol. As noted earlier, there is correlation with hyper-
tension, diabetes, BMI, and total cholesterol and these factors
could be acting as effect modifiers in the association. A
prospective longitudinal study is needed to explore this
possibility.
In the race/ethnicity subgroup analysis, the association
persisted in the age-sex model and multivariable model 1.
For non-Hispanic blacks with an additive composite score
International Journal of Inflammation 7
of 1, the association persisted in multivariable model 2. The
exact reason for the potential racial/ethnic difference in is
not clear. Non-Hispanic blacks have been reported to have
higher serum uric acid levels than other racial/ethnic groups
[34]. Similarly, non-Hispanic blacks have also been reported
to have a higher prevalence of SDB than other racial/ethnic
groups [35, 36]. Since SDB is known to be associated with
increased risk of cardiovascular disease, our results indirectly
suggest that hyperuricemia associated with sleep variables
may be a key player in the higher CVD risk in blacks.
Additional general population studies are needed to examine
racial/ethnic differences in the association between sleep
variables and high serum uric acid and confirm or refute our
initial findings.
This study has several strengths, including the large,
national sample size, high quality, standardized data collec-
tion, and the availability of information of several confound-
ing andmediating factors. Nevertheless, there are limitations.
The study design, being cross-sectional due to the nature
of the NHANES sleep variables, prohibits the generation
of inferential or temporal evaluations of the sleep variables
and uric acid. This study used self-reported sleep variables,
and there is the potential of nondifferential misclassification
bias. There were 1375 participants in NHANES with missing
data on sleep variables, who were excluded from the current
analysis. Those who were excluded due to missing data were
more significantly likely to be older, not current drinkers, and
they do not exercise regularly. The exclusion of these subjects
may have introduced selection bias to our results and our
estimates of association may be an under- or an overestimate
of the true association between sleep variables and uric acid.
In summary, this study shows that there is an initial
positive association between the sleep variables, including
daytime sleepiness, snoring more than 5 nights per week,
and an additive composite score of sleep variables with high
serum uric acid in a national study of US adults that atten-
uated with adjustment for clinical factors such as diabetes
mellitus, depression, total cholesterol, and hypertension.
Our hypothesis-forming study suggests the need to examine
the pathophysiological role of sleep risk factors with high
serum uric acid levels employing polysomnography or other
objective measures of sleep, and a longitudinal study design
to clarify the temporal nature of this relationship.
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